Adamis Pharmaceuticals reported 1.85M in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Adamis Pharmaceuticals ADMP:US 1.85M 1.85M
Adma Biologics ADMA:US $ 138.42M 43.56M
Brainstorm Cell Therapeutics BCLI:US $ 0M 0M
Cara Therapeutics CARA:US $ 0 0
Cerulean Pharma CERU:US $ 0M 0M
GlaxoSmithKline GSK:LN 33328M 9155M
Glaxosmithkline GSK:US $ 33328M 9155M
Merk MRK:US $ 31794M 1308M
Pfizer PFE:US $ 36301M 2135M
Redhill Biopharma RDHL:US $ 87.81M 0.3M